ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,289Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 244

$1.44M Total Retail Price of All Prescriptions

Rank: 3 out of 244

627 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 627 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

2% of this provider’s 627 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 26,200 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
WARFARIN SODIUM 1,632 1,612 1 8
METOPROLOL TARTRATE 1,252 1,185 2 5
AMLODIPINE BESYLATE 1,079 988 3 2
SIMVASTATIN 1,064 992 4 1
LACTULOSE 802 778 10 5 48
BRIMONIDINE TARTRATE 794 745 6 115
RISPERIDONE 740 635 7 36
FUROSEMIDE 681 646 8 3
MIRTAZAPINE 630 605 9 13
ENALAPRIL MALEATE 625 578 10 24
LATANOPROST 528 477 11 79
OMEPRAZOLE 526 510 12 6
LEVETIRACETAM 485 442 13 39
DONEPEZIL HCL 361 352 14 9
CITALOPRAM HBR 355 340 15 15
LEVOTHYROXINE SODIUM 348 326 16 4
TAMSULOSIN HCL 348 332 16 20
NOVOLOG FLEXPEN 341 336 18 127
ALBUTEROL SULFATE 318 280 19 55
IPRATROPIUM BROMIDE 297 261 20 86
FAMOTIDINE 294 248 21 49
RANITIDINE HCL 261 223 22 34
HYDRALAZINE HCL 256 224 23 50
QUETIAPINE FUMARATE 253 234 24 31
OXYCODONE-ACETAMINOPHEN 251 209 S2 25 72
METFORMIN HCL 250 235 26 10
SANTYL 247 214 27 81
NIFEDIPINE ER 240 228 28 64
GLIPIZIDE 236 235 29 42
LOVASTATIN 235 222 30 62
HALOPERIDOL 233 207 31 105
LOSARTAN POTASSIUM 230 222 32 16
NAMENDA 212 201 33 19
LISINOPRIL 209 198 34 7
GABAPENTIN 206 185 35 14
LEVEMIR FLEXPEN 198 198 36 156
DIGOXIN 195 176 37 45
TRAVATAN Z 188 188 38 116
CLOPIDOGREL 186 180 39 29
LEVEMIR 185 180 40 159
JANUVIA 173 160 41 32
VALPROIC ACID 162 108 42 149
FINASTERIDE 158 157 43 52
DORZOLAMIDE HCL 157 157 44 257
DORZOLAMIDE-TIMOLOL 151 141 45 230
LANTUS 146 133 46 30
SINGULAIR 144 131 47 77
POTASSIUM CHLORIDE 141 139 48 25
HYDROCHLOROTHIAZIDE 139 122 49 12
BENZTROPINE MESYLATE 139 114 R 49 119
ALENDRONATE SODIUM 138 132 51 21
FENTANYL 136 100 S2 52 108
NOVOLOG 136 134 52 75
CARVEDILOL 135 123 54 23
CARBIDOPA-LEVODOPA 133 129 55 41
PLAVIX 132 131 56 38
HEPARIN SODIUM 129 126 57 113
ZOLPIDEM TARTRATE 124 119 58 28
MEGESTROL ACETATE 123 121 R 59 284
ATENOLOL 118 105 60 18
CYMBALTA 114 114 61 56
AGGRENOX 111 111 62 192
DIOVAN 109 107 63 37
DOXAZOSIN MESYLATE 105 93 64 102
CLOTRIMAZOLE-BETAMETHASONE 105 100 64 117
CLONIDINE HCL 101 100 66 87
NYSTATIN 99 84 67 83
BUDESONIDE 97 80 68 209
PREDNISONE 97 87 68 43
PRANDIN 93 93 70 111
GEMFIBROZIL 92 92 71 184
METOCLOPRAMIDE HCL 90 77 72 124
PIPERACILLIN-TAZOBACTAM 89 70 10 73 307
FLUOCINONIDE 89 80 73 216
DIVALPROEX SODIUM 88 85 75 59
AMOX TR-POTASSIUM CLAVULANATE 87 79 76 133
SEROQUEL 86 83 77 92
SPIRONOLACTONE 85 72 78 78
POLYETHYLENE GLYCOL 3350 83 81 79 33
TRICOR 81 71 80 188
VANCOMYCIN HCL 81 76 80 191
PROCRIT 80 80 82 134
MONTELUKAST SODIUM 76 62 83 151
DETROL LA 74 74 84 153
HYDROXYZINE HCL 74 71 R 84 245
HUMALOG 73 71 86 193
PHENYTOIN 73 72 86 324
MELOXICAM 73 66 86 131
LABETALOL HCL 73 54 86 96
DIVALPROEX SODIUM ER 73 56 86 173
NOVOLIN N 72 70 91 171
AZITHROMYCIN 72 68 91 70
TIMOLOL MALEATE 72 72 91 276
SILVER SULFADIAZINE 70 68 94 135
KETOCONAZOLE 70 39 94 197
NOVOLOG MIX 70-30 FLEXPEN 70 70 94 262
ISOSORBIDE DINITRATE 66 60 97 148
OLANZAPINE 66 62 97 85
AMANTADINE 63 63 99 288
CLOZAPINE 62 37 100 166
TRAZODONE HCL 61 61 101 35
METOLAZONE 59 47 102 356
MUPIROCIN 58 53 103 177
AMMONIUM LACTATE 58 51 103 101
ISOSORBIDE MONONITRATE ER 58 44 103 44
METOPROLOL SUCCINATE 57 54 106 11
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 46 107 125
RISPERDAL CONSTA 56 56 107 362
ATORVASTATIN CALCIUM 56 56 107 17
LUMIGAN 56 56 107 243
ACETAMINOPHEN-CODEINE 54 54 S3 111 177
METRONIDAZOLE 53 41 112 241
QUINAPRIL HCL 53 53 112 144
SERTRALINE HCL 52 29 114 22
EXELON 51 51 115 121
NEXIUM 51 51 115 27
ANASTROZOLE 50 37 117 300
SSD 50 49 117 158
HALOPERIDOL LACTATE 50 46 117 387
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.